Joseph Davies 3/11/25 Joseph Davies 3/11/25

Announcement - Proposed Offerings of Mandatory Convertible Preferred Stock

Proposed Offerings of Mandatory Convertible Preferred Stock

Joseph Davies 2/27/25 Joseph Davies 2/27/25

Neopharma Technologies Announces Strategic Partnership with AusChain to Assist with the Scaling and Global Rollout of NEOVAULT®

Neopharma Technologies Announces Strategic Partnership with AusChain to Assist with the Scaling and Global Rollout of NEOVAULT®.

Joseph Davies 2/5/25 Joseph Davies 2/5/25

Neopharma Technologies and Impairment Science Strengthen Partnership to Revolutionize Drug and Impairment Testing

This partnership enables Neopharma to introduce a groundbreaking solution that combines drug testing with impairment testing to fill a crucial gap in the market. With the continued expansion of marijuana legalization across the U.S. and worldwide, the need for accurate and reliable impairment assessment tools has never been greater.

Joseph Davies 12/20/24 Joseph Davies 12/20/24

Neopharma Technologies Announces Strategic Partnership to Distribute 5 Million Drug Tests with NEOVAULT® Technology

This collaboration marks a pivotal advancement in the field of next-generation drug and impairment testing, significantly elevating Neopharma Technologies’ market position and value.

Joseph Davies 11/10/24 Joseph Davies 11/10/24

Neopharma Technologies is thrilled to announce the launch of its Series A Funding Round.

Joseph Davies 9/30/24 Joseph Davies 9/30/24

Nina M. French Announced as New CEO to join Neopharma Technologies Limited

Nina French Announced as new Chief Executive Officer

Joseph Davies 9/6/21 Joseph Davies 9/6/21

Neopharma Technologies recognised as the Top 100 Healthcare Technology company in 2021. Leading the way in Drugs-of-Abuse Testing.

The Healthcare Technology Report is pleased to announce The Top 100 Healthcare Technology Companies of 2021.